In tumor immunity, YTHDF1-deficient mice have increased dendritic cell capacity to present tumor antigens, resulting in increased immune response initiation by T cells and a stronger anti-tumor CD8+ T cell response [31]. This evidence concerns the gene YTHDF1 and neoplasm.